nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone Propionate—COMT—Parkinson's disease	0.84	1	CbGaD
Testosterone Propionate—COMT—Enzymatic degradation of Dopamine by monoamine oxidase—MAOA—Parkinson's disease	0.01	0.0735	CbGpPWpGaD
Testosterone Propionate—COMT—Clearance of dopamine—SLC6A3—Parkinson's disease	0.0086	0.0629	CbGpPWpGaD
Testosterone Propionate—COMT—Clearance of dopamine—MAOA—Parkinson's disease	0.00726	0.0531	CbGpPWpGaD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—DBH—Parkinson's disease	0.0058	0.0424	CbGpPWpGaD
Testosterone Propionate—COMT—Dopamine metabolism—DDC—Parkinson's disease	0.00477	0.0349	CbGpPWpGaD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—DDC—Parkinson's disease	0.00426	0.0312	CbGpPWpGaD
Testosterone Propionate—COMT—telencephalic ventricle—Parkinson's disease	0.00424	0.208	CbGeAlD
Testosterone Propionate—COMT—Dopamine metabolism—MAOB—Parkinson's disease	0.00402	0.0294	CbGpPWpGaD
Testosterone Propionate—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Parkinson's disease	0.00392	0.0287	CbGpPWpGaD
Testosterone Propionate—COMT—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—Parkinson's disease	0.00331	0.0242	CbGpPWpGaD
Testosterone Propionate—COMT—Dopamine metabolism—NQO1—Parkinson's disease	0.0027	0.0198	CbGpPWpGaD
Testosterone Propionate—COMT—Dopamine metabolism—TH—Parkinson's disease	0.00266	0.0195	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.00264	0.0193	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Heme degradation—HMOX1—Parkinson's disease	0.00247	0.0181	CbGpPWpGaD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—TH—Parkinson's disease	0.00237	0.0174	CbGpPWpGaD
Testosterone Propionate—COMT—Dopamine metabolism—SOD1—Parkinson's disease	0.00231	0.0169	CbGpPWpGaD
Testosterone Propionate—COMT—Dopamine metabolism—MAOA—Parkinson's disease	0.00225	0.0164	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—NQO1—Parkinson's disease	0.00208	0.0152	CbGpPWpGaD
Testosterone Propionate—COMT—Biogenic Amine Synthesis—MAOA—Parkinson's disease	0.002	0.0147	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.00188	0.0138	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptors—NR4A2—Parkinson's disease	0.00186	0.0136	CbGpPWpGaD
Testosterone Propionate—COMT—Estrogen metabolism—GSTM1—Parkinson's disease	0.00159	0.0117	CbGpPWpGaD
Testosterone Propionate—AR—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.00147	0.0108	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—NQO1—Parkinson's disease	0.00125	0.00913	CbGpPWpGaD
Testosterone Propionate—Nandrolone decanoate—MAOB—Parkinson's disease	0.00119	0.37	CrCbGaD
Testosterone Propionate—COMT—brainstem—Parkinson's disease	0.00115	0.0562	CbGeAlD
Testosterone Propionate—COMT—forebrain—Parkinson's disease	0.00111	0.0543	CbGeAlD
Testosterone Propionate—CYP17A1—medulla oblongata—Parkinson's disease	0.00109	0.0536	CbGeAlD
Testosterone Propionate—UGT1A1—Porphyrin metabolism—HMOX1—Parkinson's disease	0.00107	0.00786	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—COMT—Parkinson's disease	0.00104	0.00765	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTA4—Parkinson's disease	0.000976	0.00714	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HCN3—Parkinson's disease	0.000974	0.00713	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Estrogen metabolism—GSTM1—Parkinson's disease	0.000955	0.00699	CbGpPWpGaD
Testosterone Propionate—AR—Androgen receptor signaling pathway—PARK7—Parkinson's disease	0.000941	0.00689	CbGpPWpGaD
Testosterone Propionate—COMT—cardiovascular system—Parkinson's disease	0.000936	0.0459	CbGeAlD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.000932	0.00682	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000917	0.00672	CbGpPWpGaD
Testosterone Propionate—CYP17A1—head—Parkinson's disease	0.000866	0.0425	CbGeAlD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000841	0.00616	CbGpPWpGaD
Testosterone Propionate—Nandrolone decanoate—MAOA—Parkinson's disease	0.000834	0.26	CrCbGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00083	0.00608	CbGpPWpGaD
Testosterone Propionate—CYP17A1—nervous system—Parkinson's disease	0.000822	0.0403	CbGeAlD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—KCNJ4—Parkinson's disease	0.000819	0.006	CbGpPWpGaD
Testosterone Propionate—AR—forebrain—Parkinson's disease	0.00081	0.0397	CbGeAlD
Testosterone Propionate—COMT—medulla oblongata—Parkinson's disease	0.000799	0.0392	CbGeAlD
Testosterone Propionate—CYP17A1—central nervous system—Parkinson's disease	0.000791	0.0388	CbGeAlD
Testosterone Propionate—CYP17A1—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000769	0.00563	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000759	0.00556	CbGpPWpGaD
Testosterone Propionate—COMT—midbrain—Parkinson's disease	0.000731	0.0358	CbGeAlD
Testosterone Propionate—COMT—spinal cord—Parkinson's disease	0.000713	0.035	CbGeAlD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—DLG1—Parkinson's disease	0.000707	0.00518	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.000706	0.00517	CbGpPWpGaD
Testosterone Propionate—AR—cardiovascular system—Parkinson's disease	0.000685	0.0336	CbGeAlD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000682	0.00499	CbGpPWpGaD
Testosterone Propionate—COMT—head—Parkinson's disease	0.000634	0.0311	CbGeAlD
Testosterone Propionate—CYP17A1—brain—Parkinson's disease	0.000628	0.0308	CbGeAlD
Testosterone Propionate—COMT—Neuronal System—KCNJ4—Parkinson's disease	0.000628	0.00459	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000624	0.00456	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000621	0.00455	CbGpPWpGaD
Testosterone Propionate—COMT—nervous system—Parkinson's disease	0.000601	0.0295	CbGeAlD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.000589	0.00431	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.000587	0.00429	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTA4—Parkinson's disease	0.000585	0.00428	CbGpPWpGaD
Testosterone Propionate—COMT—central nervous system—Parkinson's disease	0.000578	0.0284	CbGeAlD
Testosterone Propionate—COMT—Biological oxidations—GSTA4—Parkinson's disease	0.000571	0.00418	CbGpPWpGaD
Testosterone Propionate—COMT—cerebellum—Parkinson's disease	0.000565	0.0277	CbGeAlD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000563	0.00412	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000553	0.00405	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTA4—Parkinson's disease	0.000547	0.004	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—DLG1—Parkinson's disease	0.000542	0.00397	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000539	0.00395	CbGpPWpGaD
Testosterone Propionate—AR—spinal cord—Parkinson's disease	0.000522	0.0256	CbGeAlD
Testosterone Propionate—CYP17A1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000513	0.00376	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—MAOB—Parkinson's disease	0.000509	0.00372	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTP1—Parkinson's disease	0.000488	0.00357	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—MAOB—Parkinson's disease	0.000487	0.00357	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00047	0.00344	CbGpPWpGaD
Testosterone Propionate—AR—head—Parkinson's disease	0.000464	0.0227	CbGeAlD
Testosterone Propionate—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.000459	0.00336	CbGpPWpGaD
Testosterone Propionate—COMT—brain—Parkinson's disease	0.000459	0.0225	CbGeAlD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000456	0.00334	CbGpPWpGaD
Testosterone Propionate—COMT—Phase II conjugation—GSTM1—Parkinson's disease	0.000448	0.00328	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.000441	0.00323	CbGpPWpGaD
Testosterone Propionate—AR—nervous system—Parkinson's disease	0.00044	0.0216	CbGeAlD
Testosterone Propionate—COMT—Neuronal System—GRIK1—Parkinson's disease	0.000424	0.0031	CbGpPWpGaD
Testosterone Propionate—AR—central nervous system—Parkinson's disease	0.000423	0.0208	CbGeAlD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTA4—Parkinson's disease	0.00039	0.00285	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP2D6—Parkinson's disease	0.000378	0.00277	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000373	0.00273	CbGpPWpGaD
Testosterone Propionate—AR—FOXA1 transcription factor network—INS—Parkinson's disease	0.00037	0.00271	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP2D6—Parkinson's disease	0.000362	0.00265	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000361	0.00264	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—GRIK2—Parkinson's disease	0.00036	0.00264	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000357	0.00261	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—SLC18A2—Parkinson's disease	0.000349	0.00256	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—CYP2E1—Parkinson's disease	0.000346	0.00253	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000345	0.00253	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTA4—Parkinson's disease	0.000342	0.0025	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000341	0.0025	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000337	0.00247	CbGpPWpGaD
Testosterone Propionate—AR—brain—Parkinson's disease	0.000336	0.0165	CbGeAlD
Testosterone Propionate—CYP17A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000331	0.00242	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000331	0.00242	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000327	0.00239	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.00031	0.00227	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—MAOB—Parkinson's disease	0.000305	0.00223	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000303	0.00222	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000303	0.00222	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000299	0.00219	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000297	0.00217	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—COMT—Parkinson's disease	0.000294	0.00215	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTP1—Parkinson's disease	0.000292	0.00214	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000286	0.0021	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000285	0.00209	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTP1—Parkinson's disease	0.000285	0.00209	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—MAOA—Parkinson's disease	0.000285	0.00208	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000281	0.00206	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000281	0.00206	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—CHRNA4—Parkinson's disease	0.000276	0.00202	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—COMT—Parkinson's disease	0.000274	0.00201	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTP1—Parkinson's disease	0.000273	0.002	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Biological oxidations—MAOA—Parkinson's disease	0.000273	0.002	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—COMT—Parkinson's disease	0.000271	0.00198	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000269	0.00197	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Phase II conjugation—GSTM1—Parkinson's disease	0.000268	0.00197	CbGpPWpGaD
Testosterone Propionate—COMT—Biological oxidations—GSTM1—Parkinson's disease	0.000262	0.00192	CbGpPWpGaD
Testosterone Propionate—COMT—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000259	0.00189	CbGpPWpGaD
Testosterone Propionate—AR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.000254	0.00186	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—HSPA8—Parkinson's disease	0.000253	0.00185	CbGpPWpGaD
Testosterone Propionate—COMT—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000252	0.00185	CbGpPWpGaD
Testosterone Propionate—Megestrol acetate—ABCB1—Parkinson's disease	0.000252	0.0784	CrCbGaD
Testosterone Propionate—CYP17A1—Biological oxidations—GSTM1—Parkinson's disease	0.000251	0.00184	CbGpPWpGaD
Testosterone Propionate—Testosterone—MAOA—Parkinson's disease	0.000248	0.0771	CrCbGaD
Testosterone Propionate—CYP17A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000248	0.00181	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.000246	0.0018	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—DLG4—Parkinson's disease	0.000238	0.00174	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000237	0.00173	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—NQO1—Parkinson's disease	0.000234	0.00171	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—GRIN2B—Parkinson's disease	0.000232	0.0017	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—HSPA1A—Parkinson's disease	0.000232	0.0017	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—SLC6A3—Parkinson's disease	0.00023	0.00169	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—SLC6A3—Parkinson's disease	0.000229	0.00168	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2D6—Parkinson's disease	0.000227	0.00166	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000223	0.00164	CbGpPWpGaD
Testosterone Propionate—AR—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.000218	0.0016	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.000209	0.00153	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000207	0.00152	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000207	0.00152	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000204	0.0015	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.0002	0.00147	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTP1—Parkinson's disease	0.000195	0.00143	CbGpPWpGaD
Testosterone Propionate—COMT—Neuronal System—MAOA—Parkinson's disease	0.000193	0.00141	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—HMOX1—Parkinson's disease	0.000192	0.00141	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000189	0.00138	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MCCC1—Parkinson's disease	0.000186	0.00136	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ND3—Parkinson's disease	0.000186	0.00136	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—HGF—Parkinson's disease	0.000179	0.00131	CbGpPWpGaD
Testosterone Propionate—UGT1A1—NRF2 pathway—GSTM1—Parkinson's disease	0.000179	0.00131	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ND3—Parkinson's disease	0.000178	0.0013	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MCCC1—Parkinson's disease	0.000178	0.0013	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000178	0.0013	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TALDO1—Parkinson's disease	0.000175	0.00128	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—OMD—Parkinson's disease	0.000175	0.00128	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—PRKRA—Parkinson's disease	0.000173	0.00127	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.000173	0.00127	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—COMT—Parkinson's disease	0.000172	0.00126	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000172	0.00126	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTP1—Parkinson's disease	0.000171	0.00125	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—MAOA—Parkinson's disease	0.00017	0.00125	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00017	0.00125	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—COMT—Parkinson's disease	0.000169	0.00124	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000169	0.00124	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000169	0.00123	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.000167	0.00123	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—OMD—Parkinson's disease	0.000167	0.00123	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TALDO1—Parkinson's disease	0.000167	0.00123	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NDUFB11—Parkinson's disease	0.000166	0.00121	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NDUFB11—Parkinson's disease	0.000159	0.00116	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GCH1—Parkinson's disease	0.000158	0.00116	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Biological oxidations—GSTM1—Parkinson's disease	0.000157	0.00115	CbGpPWpGaD
Testosterone Propionate—Spironolactone—ABCB1—Parkinson's disease	0.000157	0.0487	CrCbGaD
Testosterone Propionate—UGT1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000155	0.00113	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GCH1—Parkinson's disease	0.000151	0.00111	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.000151	0.00111	CbGpPWpGaD
Testosterone Propionate—Norethindrone—ABCB1—Parkinson's disease	0.000145	0.0453	CrCbGaD
Testosterone Propionate—COMT—Metabolism—GBA—Parkinson's disease	0.000141	0.00103	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—FBP1—Parkinson's disease	0.000141	0.00103	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—DBH—Parkinson's disease	0.000141	0.00103	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000137	0.000999	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—FBP1—Parkinson's disease	0.000135	0.000987	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—DBH—Parkinson's disease	0.000135	0.000987	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GBA—Parkinson's disease	0.000135	0.000987	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—TAF1—Parkinson's disease	0.000122	0.000894	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—NR4A2—Parkinson's disease	0.000122	0.000894	CbGpPWpGaD
Testosterone Propionate—Progesterone—CYP2D6—Parkinson's disease	0.000119	0.0369	CrCbGaD
Testosterone Propionate—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000114	0.000837	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ND3—Parkinson's disease	0.000111	0.000815	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MCCC1—Parkinson's disease	0.000111	0.000815	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—OMD—Parkinson's disease	0.000105	0.000766	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TALDO1—Parkinson's disease	0.000105	0.000766	CbGpPWpGaD
Testosterone Propionate—Hydrocortisone—ABCB1—Parkinson's disease	0.000104	0.0324	CrCbGaD
Testosterone Propionate—COMT—Metabolism—DDC—Parkinson's disease	0.000103	0.000757	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000103	0.000751	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.0001	0.000734	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.0001	0.000732	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NDUFB11—Parkinson's disease	9.92e-05	0.000726	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—DDC—Parkinson's disease	9.9e-05	0.000725	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPL6—Parkinson's disease	9.76e-05	0.000715	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTA4—Parkinson's disease	9.76e-05	0.000715	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GCH1—Parkinson's disease	9.47e-05	0.000693	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTA4—Parkinson's disease	9.35e-05	0.000684	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.23e-05	0.000676	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—PLA2G6—Parkinson's disease	8.79e-05	0.000644	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MAOB—Parkinson's disease	8.7e-05	0.000637	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	8.51e-05	0.000623	CbGpPWpGaD
Testosterone Propionate—Progesterone—ABCB1—Parkinson's disease	8.48e-05	0.0264	CrCbGaD
Testosterone Propionate—UGT1A1—Metabolism—GBA—Parkinson's disease	8.44e-05	0.000618	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DBH—Parkinson's disease	8.44e-05	0.000618	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—FBP1—Parkinson's disease	8.44e-05	0.000618	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—PLA2G6—Parkinson's disease	8.42e-05	0.000616	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MAOB—Parkinson's disease	8.33e-05	0.00061	CbGpPWpGaD
Testosterone Propionate—Testosterone—ABCB1—Parkinson's disease	8.01e-05	0.0249	CrCbGaD
Testosterone Propionate—CYP17A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	7.93e-05	0.000581	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	7.82e-05	0.000572	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPL23A—Parkinson's disease	7.4e-05	0.000542	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPL14—Parkinson's disease	7.4e-05	0.000542	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.27e-05	0.000532	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—RPS8—Parkinson's disease	6.9e-05	0.000505	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2D6—Parkinson's disease	6.47e-05	0.000473	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CTGF—Parkinson's disease	6.35e-05	0.000465	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2D6—Parkinson's disease	6.19e-05	0.000453	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—DDC—Parkinson's disease	6.19e-05	0.000453	CbGpPWpGaD
Testosterone Propionate—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	6.19e-05	0.000453	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CTGF—Parkinson's disease	6.08e-05	0.000445	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYP2E1—Parkinson's disease	5.92e-05	0.000433	CbGpPWpGaD
Testosterone Propionate—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.87e-05	0.00043	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—NQO1—Parkinson's disease	5.85e-05	0.000428	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTA4—Parkinson's disease	5.85e-05	0.000428	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—TH—Parkinson's disease	5.76e-05	0.000422	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYP2E1—Parkinson's disease	5.66e-05	0.000415	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—NQO1—Parkinson's disease	5.6e-05	0.00041	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—CYCS—Parkinson's disease	5.53e-05	0.000405	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HSPA8—Parkinson's disease	5.53e-05	0.000405	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—TH—Parkinson's disease	5.52e-05	0.000404	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—CTGF—Parkinson's disease	5.51e-05	0.000403	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—CYCS—Parkinson's disease	5.3e-05	0.000388	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—PLA2G6—Parkinson's disease	5.27e-05	0.000386	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MAOB—Parkinson's disease	5.21e-05	0.000382	CbGpPWpGaD
Testosterone Propionate—AR—Gene Expression—HSPA1A—Parkinson's disease	5.03e-05	0.000369	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTP1—Parkinson's disease	4.88e-05	0.000357	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MAOA—Parkinson's disease	4.87e-05	0.000356	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—HMOX1—Parkinson's disease	4.81e-05	0.000352	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—COMT—Parkinson's disease	4.69e-05	0.000344	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTP1—Parkinson's disease	4.67e-05	0.000342	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MAOA—Parkinson's disease	4.66e-05	0.000341	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—ABCB1—Parkinson's disease	4.62e-05	0.000338	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—HMOX1—Parkinson's disease	4.61e-05	0.000337	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GSTM1—Parkinson's disease	4.48e-05	0.000328	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—ABCB1—Parkinson's disease	4.42e-05	0.000324	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GSTM1—Parkinson's disease	4.29e-05	0.000314	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—GPX1—Parkinson's disease	4.29e-05	0.000314	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—GPX1—Parkinson's disease	4.11e-05	0.000301	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—MTHFR—Parkinson's disease	3.96e-05	0.00029	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2D6—Parkinson's disease	3.87e-05	0.000284	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CTGF—Parkinson's disease	3.8e-05	0.000278	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—MTHFR—Parkinson's disease	3.79e-05	0.000278	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—APOE—Parkinson's disease	3.69e-05	0.00027	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYP2E1—Parkinson's disease	3.54e-05	0.000259	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—APOE—Parkinson's disease	3.53e-05	0.000259	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—NQO1—Parkinson's disease	3.5e-05	0.000257	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—TH—Parkinson's disease	3.45e-05	0.000253	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—CYCS—Parkinson's disease	3.32e-05	0.000243	CbGpPWpGaD
Testosterone Propionate—COMT—Metabolism—INS—Parkinson's disease	3.15e-05	0.000231	CbGpPWpGaD
Testosterone Propionate—CYP17A1—Metabolism—INS—Parkinson's disease	3.02e-05	0.000221	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—COMT—Parkinson's disease	2.94e-05	0.000215	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTP1—Parkinson's disease	2.92e-05	0.000214	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MAOA—Parkinson's disease	2.92e-05	0.000213	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—HMOX1—Parkinson's disease	2.88e-05	0.000211	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—ABCB1—Parkinson's disease	2.77e-05	0.000203	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GSTM1—Parkinson's disease	2.69e-05	0.000197	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—GPX1—Parkinson's disease	2.57e-05	0.000188	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—MTHFR—Parkinson's disease	2.37e-05	0.000174	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—APOE—Parkinson's disease	2.21e-05	0.000162	CbGpPWpGaD
Testosterone Propionate—UGT1A1—Metabolism—INS—Parkinson's disease	1.89e-05	0.000138	CbGpPWpGaD
